Hebei Changshan Biochemical Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 294.32 million compared to CNY 501.92 million a year ago. Net loss was CNY 61.67 million compared to net income of CNY 4.54 million a year ago.

Basic loss per share from continuing operations was CNY 0.0671 compared to basic earnings per share from continuing operations of CNY 0.0049 a year ago. Diluted loss per share from continuing operations was CNY 0.0671 compared to diluted earnings per share from continuing operations of CNY 0.0049 a year ago.